Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 1;210 Suppl 1(0 1):S143-51.
doi: 10.1093/infdis/jit588.

Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program

Affiliations

Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program

Carla Magda Allan S Domingues et al. J Infect Dis. .

Abstract

In August 2012, the Brazilian Ministry of Health introduced inactivated polio vaccine (IPV) as part of sequential polio vaccination schedule for all infants beginning their primary vaccination series. The revised childhood immunization schedule included 2 doses of IPV at 2 and 4 months of age followed by 2 doses of oral polio vaccine (OPV) at 6 and 15 months of age. One annual national polio immunization day was maintained to provide OPV to all children aged 6 to 59 months. The decision to introduce IPV was based on preventing rare cases of vaccine-associated paralytic polio, financially sustaining IPV introduction, ensuring equitable access to IPV, and preparing for future OPV cessation following global eradication. Introducing IPV during a national multivaccination campaign led to rapid uptake, despite challenges with local vaccine supply due to high wastage rates. Continuous monitoring is required to achieve high coverage with the sequential polio vaccine schedule.

Keywords: Brazil; acute flaccid paralysis; inactivated polio vaccine; poliomyelitis; vaccination schedule.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. Carla Domingues, Sirlene Pereira, Ana Carolina Marreiros, and Nair Menezes are employed by the Brazilian Ministry of Health, which purchases inactivated polio vaccine for use in the national immunization program. In Brazil, inactivated polio vaccine is purchased in bulk from Sanofi Pasteur and distributed by Bio-Manguinhos Institute, a public vaccine manufacturer funded by the Brazilian Ministry of Health. All other authors report no potential conflicts.

All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed

Figures

Figure 1
Figure 1
A, Municipalities reporting <95% or ≥95% coverage with 3 doses of oral polio vaccine (OPV3) among children aged <1 year, January–December, 2011. B, Municipalities reporting <95% or ≥95% coverage (based on monthly target population) with 1 dose of inactivated polio vaccine (IPV1) among children aged <1 year, September–December, 2012.

Similar articles

Cited by

References

    1. World Health Organization. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec. 2010;85:213–28. - PubMed
    1. Pan American Health Organization. Final report of the XVIII Technical Advisory Group (TAG) meeting on vaccine-preventable diseases of the Pan American Health Organization. Washington, DC: Pan American Health Organization; 2011. Immunization: prioritizing vunerable populations; pp. 15–6.
    1. Ministry of Health. Série C Projetos e Programas e Relatórios. Brasília, Brazil: Ministry of Health; 2003. Programa Nacional de Imunizações—30 anos.
    1. Ministry of Health. Informe Técnico da Introdução da Vacina Inativada Poliomielite. Departamento de Vigilância Epidemiológica; [Accessed 1 October 2013]. http://portal.saude.gov.br/portal/arquivos/pdf/informe_introducao_vacina....
    1. Risi JB., Jr The control of poliomyelitis in Brazil. Rev Infect Dis. 1984;6 (suppl 2):S400–3. - PubMed

Substances